Blue Ocean Capital Group
Overview
Blue Ocean Capital Group is a life science-focused venture capital investment firm that invests in innovative biotech hubs in Greater China, the USA, and Northern Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Signet Therapeutics | Jan 2026 | Series A | Co-investor |
| Innorna | Mar 2022 | Series B | Co-investor |
| Cure Genetics | Jan 2022 | Series B | Co-investor |
| Koka Lifesciences | Oct 2021 | Early Funding | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Blue Ocean Capital Group based?
Blue Ocean Capital Group is headquartered in Shenzhen, China.
When was Blue Ocean Capital Group founded?
Blue Ocean Capital Group was founded in 2015.
How many portfolio companies does Blue Ocean Capital Group have?
Blue Ocean Capital Group has 6 portfolio companies in Caplight's dataset.
What are some companies in Blue Ocean Capital Group's portfolio?
Recent investments visible on Caplight include Signet Therapeutics, Innorna, Cure Genetics, Signet Therapeutics, Koka Lifesciences.
What was Blue Ocean Capital Group's most recent investment?
Blue Ocean Capital Group's most recent investment on Caplight was in Signet Therapeutics in 2026.
What sectors does Blue Ocean Capital Group focus on?
Blue Ocean Capital Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Blue Ocean Capital Group focus on?
Blue Ocean Capital Group typically invests at the Early stage.
What is Blue Ocean Capital Group's AUM?
Blue Ocean Capital Group's assets under management are estimated between $300.0M and $300.0M.